IUSV 📈 iShares Core S&P U.S. Value - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US4642876639 • Large Value
IUSV: Stocks, Futures, Options, Swaps, Cash
The iShares Core S&P U.S. Value ETF, listed on the NASDAQ under the ticker IUSV, is designed to track the performance of the S&P U.S. Value Index. This index is comprised of stocks of U.S. companies that are characterized by their value characteristics, such as lower price-to-book ratios and lower earnings growth expectations. The fund's investment strategy involves investing at least 80% of its assets in the component securities of its underlying index, which includes a diverse range of U.S. value stocks. Additionally, the fund may invest in other securities that have economic characteristics substantially identical to those of the index components, allowing for some flexibility in portfolio management.
Furthermore, the fund has the ability to allocate up to 20% of its assets to certain derivatives, such as futures, options, and swap contracts, as well as cash and cash equivalents. This allows the fund managers to engage in various investment strategies, including hedging and portfolio optimization, in order to achieve the fund's investment objectives. The fund is domiciled in the United States and has an International Securities Identification Number (ISIN) of US4642876639. As an exchange-traded fund (ETF), it offers investors a convenient and transparent way to gain exposure to the U.S. value stock market, with the added benefit of trading flexibility and typically lower fees compared to actively managed funds.
In terms of its categorization, the iShares Core S&P U.S. Value ETF falls under the large value ETF category, indicating that it focuses on investing in larger-cap U.S. companies that exhibit value characteristics. The fund's investment approach is designed to provide broad diversification and exposure to the U.S. value stock market, making it a potential option for investors seeking to incorporate a value investing strategy into their portfolios. For more information about the fund, including its holdings, performance, and other details, investors can visit the iShares website at http://www.ishares.com.
Additional Sources for IUSV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IUSV ETF Overview
Market Cap in USD | 20,431m |
Category | Large Value |
TER | 0.04% |
IPO / Inception | 2000-07-24 |
IUSV ETF Ratings
Growth 5y | 78.4% |
Fundamental | - |
Dividend | 46.5% |
Rel. Strength Industry | -13.4 |
Analysts | - |
Fair Price Momentum | 94.07 USD |
Fair Price DCF | - |
IUSV Dividends
Dividend Yield 12m | 1.55% |
Yield on Cost 5y | 2.56% |
Annual Growth 5y | 1.42% |
Payout Consistency | 96.3% |
IUSV Growth Ratios
Growth Correlation 3m | 40.4% |
Growth Correlation 12m | 94.5% |
Growth Correlation 5y | 93% |
CAGR 5y | 10.52% |
CAGR/Mean DD 5y | 2.05 |
Sharpe Ratio 12m | 0.83 |
Alpha | -10.94 |
Beta | 0.92 |
Volatility | 18.64% |
Current Volume | 1715.9k |
Average Volume 20d | 770.4k |
As of December 22, 2024, the stock is trading at USD 93.02 with a total of 1,715,902 shares traded.
Over the past week, the price has changed by -2.73%, over one month by -3.58%, over three months by -0.89% and over the past year by +14.90%.
Yes. Based on ValueRay Analyses, iShares Core S&P U.S. Value (NASDAQ:IUSV) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 78.39 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IUSV as of December 2024 is 94.07. This means that IUSV is currently overvalued and has a potential downside of 1.13%.
iShares Core S&P U.S. Value has no consensus analysts rating.
According to ValueRays Forecast Model, IUSV iShares Core S&P U.S. Value will be worth about 104.4 in December 2025. The stock is currently trading at 93.02. This means that the stock has a potential upside of +12.18%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 104.4 | 12.2% |